Middle East Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)
The “Middle East Active Pharmaceutical Ingredients (API) Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Based on the geography the market is categorized into Saudi Arabia, UAE and rest of Middle East.
The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.
Market Size Estimations
The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.
Company Profiling
This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.
Report Highlights:
The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.
Market Size Estimations
The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.
Company Profiling
This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.
Report Highlights:
- Market share assessments for all the mentioned market segments and sub-segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years for all the given segments
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping, mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPES OF API
5.1 Introduction
5.2 Synthetic chemical API
5.3 Biological API
6 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURING
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing
7 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATIONS
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder
8 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY
8.1 Middle East
8.1.1 Saudi Arabia
8.1.2 UAE
8.1.3 Rest of Middle East
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (Saudi Arabia)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac
2 PREFACE
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPES OF API
5.1 Introduction
5.2 Synthetic chemical API
5.3 Biological API
6 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURING
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing
7 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATIONS
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder
8 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY
8.1 Middle East
8.1.1 Saudi Arabia
8.1.2 UAE
8.1.3 Rest of Middle East
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (Saudi Arabia)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac
LIST OF TABLES
1 Middle East Chemical Seed treatment Market, By Countries (2012-2022) ($MN)
2 Middle East Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
3 Saudi Arabia Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
4 UAE Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
5 Rest of Middle East Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
6 Middle East Active Pharmaceutical Ingredients Market, By Synthetic chemical API (2012-2022) ($MN)
7 Middle East Active Pharmaceutical Ingredients Market, By Biological API (2012-2022) ($MN)
8 Middle East Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
9 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
10 UAE Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
11 Rest of Middle East Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
12 Middle East Active Pharmaceutical Ingredients Market, By Captive (or in-house) manufacturing (2012-2022) ($MN)
13 Middle East Active Pharmaceutical Ingredients Market, By Contract manufacturing (2012-2022) ($MN)
14 Middle East Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
15 Saudi Arabia Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
16 UAE Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
17 Rest of Middle East Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
18 Middle East Active Pharmaceutical Ingredients Market, By Oncology (2012-2022) ($MN)
19 Middle East Active Pharmaceutical Ingredients Market, By Anti-Infectives (2012-2022) ($MN)
20 Middle East Active Pharmaceutical Ingredients Market, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
21 Middle East Active Pharmaceutical Ingredients Market, By Gastrointestinal disorder (2012-2022) ($MN)
22 Middle East Active Pharmaceutical Ingredients Market, By Hormonal-related disorder (2012-2022) ($MN)
23 Middle East Active Pharmaceutical Ingredients Market, By Metabolic disorder (2012-2022) ($MN)
24 Middle East Active Pharmaceutical Ingredients Market, By Musculo-skeletal disorder (2012-2022) ($MN)
1 Middle East Chemical Seed treatment Market, By Countries (2012-2022) ($MN)
2 Middle East Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
3 Saudi Arabia Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
4 UAE Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
5 Rest of Middle East Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
6 Middle East Active Pharmaceutical Ingredients Market, By Synthetic chemical API (2012-2022) ($MN)
7 Middle East Active Pharmaceutical Ingredients Market, By Biological API (2012-2022) ($MN)
8 Middle East Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
9 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
10 UAE Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
11 Rest of Middle East Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
12 Middle East Active Pharmaceutical Ingredients Market, By Captive (or in-house) manufacturing (2012-2022) ($MN)
13 Middle East Active Pharmaceutical Ingredients Market, By Contract manufacturing (2012-2022) ($MN)
14 Middle East Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
15 Saudi Arabia Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
16 UAE Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
17 Rest of Middle East Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
18 Middle East Active Pharmaceutical Ingredients Market, By Oncology (2012-2022) ($MN)
19 Middle East Active Pharmaceutical Ingredients Market, By Anti-Infectives (2012-2022) ($MN)
20 Middle East Active Pharmaceutical Ingredients Market, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
21 Middle East Active Pharmaceutical Ingredients Market, By Gastrointestinal disorder (2012-2022) ($MN)
22 Middle East Active Pharmaceutical Ingredients Market, By Hormonal-related disorder (2012-2022) ($MN)
23 Middle East Active Pharmaceutical Ingredients Market, By Metabolic disorder (2012-2022) ($MN)
24 Middle East Active Pharmaceutical Ingredients Market, By Musculo-skeletal disorder (2012-2022) ($MN)
